Table 2.

Fully-adjusted, survey-weighted associations between serum PBDE concentrations and having a current thyroid problem. Adjusted for: age, race/ethnicity, BMI, education, smoking, alcohol consumption, and current hormone use

	BDE47 n = 1075		BDE99 n = 1061		BDE100 n = 1089		BDE153 n = 1089		Sum BDEs n = 1061
	OR	(95 % CI)	OR	(95 % CI)	OR	(95 % CI)	OR	(95 % CI)	OR	(95 % CI)
Men and Women Combined
Q1 + Q2 (ref)	1		1		1		1		1
Q3	0.55	(0.20–1.49)	0.93	(0.38–2.27)	0.74	(0.44–1.25)	0.92	(0.30–2.84)	0.57	(0.23–1.39)
Q4	1.32	(0.90–1.96)	1.22	(0.80–1.84)	1.13	(0.79–1.60)	1.14	(0.56–2.31)	1.09	(0.71–1.67)
	BDE47 n = 512		BDE99 n = 504		BDE100 n = 518		BDE153 n = 518		Sum BDEs n = 504
All Women
Q1 + Q2 (ref)	1		1		1		1		1
Q3	0.60	(0.19–1.85)	0.75	(0.27–2.08)	0.65	(0.27–1.54)	1.00	(0.27–3.78)	0.36**	(0.15–0.89)
Q4	1.48**	(1.05–2.09)	1.78**	(1.16–2.75)	1.50*	(0.97–2.31)	1.44	(0.68–3.05)	1.61**	(1.10–2.36)
	BDE47 n = 236		BDE99 n = 233		BDE100 n = 240		BDE153 n = 240		Sum BDEs n = 233
Postmenopausal Women
Q1 + Q2 (ref)	1		1		1		1		1
Q3	0.81	(0.24–2.71)	0.99	(0.34–2.93)	0.23**	(0.07–0.68)	0.50	(0.13–1.90)	0.54	(0.15–1.97)
Q4	2.15*	(0.86–5.37)	3.63**	(1.12–11.8)	2.02*	(0.93–4.36)	1.25	(0.49–3.21)	2.20*	(0.92–5.26)

***p < 0.01,**p < 0.05, *p < 0.1